Cita APA

Azaro Pedrazzoli, A. B., De Vos, F., Sepúlveda, J. M., Yung, W. K. A., Wen, P. Y., & van den Bent, M. (2020). A Phase Ib/II, open-label, multicenter study of INC280 (capmatinib) alone and in combination with buparlisib (BKM120) in adult patients with recurrent glioblastoma.

Citación estilo Chicago

Azaro Pedrazzoli, Analía Beatriz, Filip De Vos, Juan Manuel Sepúlveda, W. K. Alfred Yung, Patrick Y. Wen, y Martin van den Bent. A Phase Ib/II, Open-label, Multicenter Study of INC280 (capmatinib) Alone and in Combination With Buparlisib (BKM120) in Adult Patients With Recurrent Glioblastoma. 2020.

Cita MLA

Azaro Pedrazzoli, Analía Beatriz, et al. A Phase Ib/II, Open-label, Multicenter Study of INC280 (capmatinib) Alone and in Combination With Buparlisib (BKM120) in Adult Patients With Recurrent Glioblastoma. 2020.